Thomas A. MCCOURT - Jun 30, 2022 Form 4 Insider Report for IRONWOOD PHARMACEUTICALS INC (IRWD)

Role
Chief Executive Officer, Director
Signature
/s/ Ronald Silver, Attorney-in-Fact
Stock symbol
IRWD
Transactions as of
Jun 30, 2022
Transactions value $
-$231,125
Form type
4
Date filed
7/5/2022, 04:05 PM
Previous filing
May 25, 2022
Next filing
Aug 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IRWD Class A Common Stock Sale -$231K -20K -2.5% $11.58 779K Jun 30, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.